Company profile
Halia Therapeutics company profile
Halia Therapeutics is a preclinical-stage biopharmaceutical company manufacturing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases. Halia Therapeutics does this by advancing innovative medicines that target the immune system's response to resolve chronic inflammation and eliminate the damage caused by aberrantly activated immune responses. Halia Therapeutics takes a novel approach to drug discovery by translating advances in understanding of the role of inflammation in human pathologies such as cancer and neurodegenerative diseases.
Business identity
- Website
- https://haliatx.com
- Phone number
- 801-753-5707
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2017-01-01, Year
Headquarters
- Headquarters
- Post, Texas, United States
- Country code
- US
- Continent
- North America